Medical Communications

A long-acting, injectable HIV drug combo is to be tested in a clinical trial of 350 volunteers with HIV. The …

Bristol-Myers Squibb’s blockbuster immunotherapy Opdivo (nivolumab) has hit a hurdle, failing its primary endpoint in a Phase 3 trial investigating …

Gilead Sciences has agreed to donate 11 years’ worth PrEP drugs for up to 200,000 individuals each year, following “discussions …

Nearly 5,000 EU nurses and midwifes have left the NHS over the past two years. The number of EU nationals …

Japanese multinational Takeda Pharmaceutical has agreed to sell its dry eye drug Xiidra to Swiss firm Novartis in a deal …

Patients taking some newer diabetes medications – SGLT2 inhibitors – have been warned that they may be at risk of …

MedImmune’s Vice President of Clincial Development Oncology, Mohammed Dar has joined British biotech Immunocore as the company’s new CMO. Dar …

The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume …

Gilead has announced that Robin Washington, the company’s Senior Vice President and Chief Financial Officer of more than a decade, …

The NHS is sick. According to politicians and NHS chiefs, the cure involves a strong dose of mHealth. Louis Goss …

GSK and partner Innoviva have lifted the curtain on new Phase 3 data for their single inhaler triple therapy Trelegy …

The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume …

This week was marked by the failure of two Phase 3 trials after both Eli Lilly and Gilead suffered from …

The founder of opioid drugmaker Insys Therapeutics has been found guilty of bribing doctors in order to persuade them to …

The risk of transmitting HIV through gay sex when the infected partner’s HIV load has been fully supressed by antiretroviral …